Loading…
Lobbying Spend
—
Filings
19
Firms Hired
1
Active Period
2002–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
National Plan for Epilepsy Act
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1189
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: H.R.9260
Department of Defense Appropriations Act, 2027
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: H.R.9495
National Plan for Epilepsy Act
2026 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: S.494
National Plan for Epilepsy Act
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1189
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: H.R.9260
Department of Defense Appropriations Act, 2027
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: H.R.9495
National Plan for Epilepsy Act
2026 · second_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations Act (H.R.9495); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: S.494
National Plan for Epilepsy Act
2026 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1189
National Plan for Epilepsy Act
2026 · first_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act; FY2027 Department of Defense Appropriations; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: S.494
National Plan for Epilepsy Act
2025 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act. Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1189
National Plan for Epilepsy Act
2025 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Funding for epilepsy program research at CDC, NIH, DoD; S.494/H.R.1189, National Plan for Epilepsy Act. Support coverage of and access to all epilepsy treatments. Support PBM reform.
Client expense: — · Firm income: $30,000
Matched citations: S.494
Source: Senate LDA